Page 30 - Quest Diagnostics News Today

Nicholas Company Inc. lifted its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 7.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 42,835 shares of the medical research company’s stock after buying an additional 3,125 shares during the quarter. Nicholas […]

Isthmus Partners LLC bought a new stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 90,131 shares of the medical research company’s stock, valued at approximately $12,427,000. Quest Diagnostics makes up […]

Isthmus Partners LLC bought a new stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm bought 90,131 shares of the medical research company’s stock, valued at approximately $12,427,000. Quest Diagnostics makes up 1.6% of Isthmus Partners LLC’s holdings, making the stock its 20th biggest […]

The increase in substituted specimens was up 633% in 2023 compared to 2022, said Quest Diagnostics.

NORTHAMPTON, MA / ACCESSWIRE / May 29, 2024 / Quest Diagnostics: Quest colleagues from coast-to-coast marked Lab Week 2024 with a week full of activities to celebrate our medical laboratory professionals

Increasing Revenue Growth. Raising Guidance. Growth Accelerates for Fifth Consecutive Quarter, Record Federal Growth Subscription Revenue for the Fourth Quarter Increased 41% Year-Over-Year ...

StockNews.com upgraded shares of Quest Diagnostics (NYSE:DGX – Free Report) from a hold rating to a buy rating in a report issued on Friday. DGX has been the topic of several other reports. Citigroup upped their price target on Quest Diagnostics from $135.00 to $145.00 and gave the company a neutral rating in a research […]

Trexquant Investment LP bought a new stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 10,683 shares of the medical research company’s stock, valued at approximately $1,473,000. Several other hedge funds also recently modified their holdings […]

Pine Valley Investments Ltd Liability Co grew its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 27.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 21,528 shares of the medical research company’s stock after buying an additional 4,627 shares during the […]

Quest Diagnostics Incorporated (NYSE:DGX – Get Free Report) has been assigned a consensus rating of “Hold” from the twelve brokerages that are covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month target price among brokerages […]